Amantadine HCL
- Product NDC
- 72189-412
- 11-digit product format
- 721890412
- Labeler code
- 72189
- Product ID
- 72189-412_2c4cfb73-b3b1-daf3-e063-6294a90af289
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Amantadine HCL
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Direct_Rx
- Application
- ANDA209047
- Marketing category
- ANDA
- Marketing start
- 2023-01-18
- Substance
- AMANTADINE HYDROCHLORIDE
- Active strength
- 100 mg/1
- Pharmacologic classes
- Influenza A M2 Protein Inhibitor [EPC], M2 Protein Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Amantadine HCL
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| AMANTADINE HYDROCHLORIDE | 100 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | M6Q1EO9TD0 |
| Rxcui | 849389 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 72189-412-30 | Amantadine HCL | 30 in 1 BOTTLE | CAPSULE | 30 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 72189-412 | AMANTADINE HCL CAPSULE [DIRECT_RX] | 4 | Current NDC, 1 package rows | 20250123_f28c55c8-2754-a44d-e053-2a95a90ae798.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 72189-412-30 | 72189041230 | 30 CAPSULE in 1 BOTTLE (72189-412-30) | 30 capsule | 2023-01-18 | No | No | Current |